Oral sessions summaries


Ankylosing Spondylitis

Tofacitinib for the treatment of adult patients with ankylosing spondylitis: primary analysis of a phase 3, randomized, double-blind, placebo-controlled study

Atul Deodhar, MD

ACR Convergence 2020 - Oral session summaries - Abs #L11

View
Ankylosing Spondylitis

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis: 1-year results from a randomized, double-blind, placebo-controlled study with open-label extension

Atul Deodhar, MD

ACR Convergence 2020 - Oral session summaries - Abs #2023

View
Axial Spondyloarthritis

Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial

Xenofon Baraliakos, MD, PhD

ACR Convergence 2020 - Oral session summaries - Abs #0505

View
Axial Spondyloarthritis

Disease-related factors associated to atherosclerotic disease in axial spondyloarthritis. A multicenter study with 806 patients

Inigo Gonzalez-Mazon, MD

ACR Convergence 2020 - Oral session summaries - Abs #0448

View
Behçet Syndrome

Efficacy of apremilast for the treatment of manifestations of Behçet’s syndrome other than oral ulcers, including skin lesions and arthritis

Gülen Hatemi, MD

ACR Convergence 2020 - Oral session summaries - Abs #0512

View
Giant Cell Arteritis

Characteristics of giant cell arteritis flares after successful treatment with tocilizumab: results from the long-term extension of a randomized controlled phase 3 trial

Sebastian Unizony, MD

ACR Convergence 2020 - Oral session summaries - Abs #0516

View
Lupus Nephritis

Two-year results from a randomized, controlled study of obinutuzumab for proliferative lupus nephritis

Richard Furie, MD

ACR Convergence 2020 - Oral session summaries - Abs #0988

View
Psoriatic Arthritis

Multimorbidity in rheumatoid arthritis, psoriatic arthritis, gout, and osteoarthritis within the Rheumatology Informatics System for Effectiveness (RISE) registry

Bryant England, MD, PhD

ACR Convergence 2020 - Oral session summaries - Abs #2021

View
Psoriatic Arthritis

The reliability of scoring sonographic entheseal abnormalities – the Diagnostic Ultrasound Enthesitis Tool (DUET) study

Lihi Eder, MD, PhD

ACR Convergence 2020 - Oral session summaries - Abs #2021

View
Rheumatoid Arthritis

Non-obese rheumatoid arthritis patients with low low-density lipoprotein have higher coronary atherosclerosis burden, greater plaque progression and cardiovascular event risk

George Karpouzas, MD

ACR Convergence 2020 - Oral session summaries - Abs #0485

View
Rheumatoid Arthritis

Stable versus tapered and withdrawn treatment with tumor necrosis factor inhibitor in rheumatoid arthritis remission: a randomized, open-label, phase 4, non-inferiority trial

Siri Lillegraven, MD, PhD

ACR Convergence 2020 - Oral session summaries - Abs #2010

View
Rheumatoid Arthritis

Incidence and risk factors for herpes zoster in rheumatoid arthritis patients receiving upadacitinib

Kevin Winthrop, MD, MPH

ACR Convergence 2020 - Oral session summaries - Abs #1002

View
Rheumatoid Arthritis

Can a Clinical Disease Activity Index based on patient-reported joint counts (PT-CDAI) be used to inform target-based care in telemedicine? An analysis of 2 early RA cohort studies

Vivian Bykerk, MD

ACR Convergence 2020 - Oral session summaries - Abs #0483

View